No Data
Optimistic Investors Push Tuoxin Pharmaceutical Group Co.,Ltd. (SZSE:301089) Shares Up 32% But Growth Is Lacking
We're Interested To See How Tuoxin Pharmaceutical GroupLtd (SZSE:301089) Uses Its Cash Hoard To Grow
Tuoxin Pharmaceutical: 2024 Annual Report
Tuoxin Pharmaceutical: Report for the first quarter of 2025
Tuoxin Pharmaceutical: 2024 Annual Report Summary
Taoxin Pharmaceutical (301089.SZ): Net loss of 3.5647 million yuan in the first quarter.
On April 25, Gelonghui reported that Toxin Pharmaceutical (301089.SZ) announced its first quarter report for 2025. During the reporting period, revenue reached 96.9947 million yuan, a decrease of 10.46% year-on-year; the net income attributable to shareholders of the listed company was -3.5647 million yuan, and the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -5.9527 million yuan, with an EPS of -0.03 yuan.
